Rituxan News
Most Popular Rituxan Story
Arbitrator sides with Biogen in Rituxan dispute
An arbitrator has ruled that Genentech must halt several trials until Biogen Idec says they can move forward. Genentech and Biogen Idec are partners on the blockbuster cancer and rheumatoid arthritis... Read more...
Latest Headlines
- June 17, 2009
- April 29, 2008
- April 15, 2008
- March 19, 2008
- January 29, 2008
- January 15, 2008
- November 8, 2007
- October 29, 2007
- October 24, 2007
- October 12, 2007
- September 12, 2007
- January 24, 2007
- January 22, 2007
- January 9, 2007
- December 19, 2006
- December 19, 2006
- December 18, 2006
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
